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Abstract
Background: Coronary Endarterectomy (CE) in patients undergoing coronary artery bypass graft
(CABG) surgery has been shown to be beneficial in those with diffuse coronary artery disease.
There are no published data on its role and benefit in patients undergoing more complex
operations. We present our experience with CE in patients undergoing valve surgery with
concomitant CABG.
Materials and methods: Between 1989 and 2003, 237 patients underwent CABG with valve
surgery under a single surgeon at our institution. Of these, 41 patients needed CE. Data was
retrospectively obtained from hospital records and database. Further follow-up was obtained by
telephone interview. All variables were analyzed by univariate analysis for significant factors relating
to hospital mortality. Morbidity and long term survival was also studied. There were 29 males and
12 females with a mean age of 67.4 ± 8.1 and body mass index of 26.3 ± 3.3. Their mean euroscore
was 7.6 ± 3.2 and the log euro score was 12.2 ± 16.1.
Results: Thirty-two patients were discharged from the intensive therapy unit within 48 hours after
surgery. Average hospital stay was 12.7 ± 10.43 days. Thirty day mortality was 9.8%. Six late deaths
occurred during the 14 year follow up. Ten year survival was 57.2% (95% CL 37.8%–86.6%). Three
of the survivors had Class II symptoms, with one requiring nitrates. None required further
percutaneous or surgical intervention. We compared the result with the available mortality figure
from the SCTS database.
Conclusion: Compared to the SCTS database for these patients, we have observed that CE does
not increase the mortality in combined procedures. By accomplishing revascularization in areas
deemed ungraftable, we have shown an added survival benefit in this group of patients.
Introduction
Coronary endarterectomy (CE), first described by Bailey et
al in 1957, has been shown to benefit patients with
advanced coronary atheroma by providing complete
revascularization. [1] The safety and long-term efficacy of
the procedure, although controversial, has been demon-
strated in earlier studies. [2,3]
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There have been no studies on the effect of endarterec-
tomy in patients undergoing valve surgery with concomi-
tant coronary bypass. This study was aimed at auditing the
mortality and morbidity of patients undergoing com-
bined valvular and coronary artery surgery with additional
CE. We also looked at the symptomatic relief and long-
term survival in this group of patients.
Materials and methods
Patients who underwent coronary artery bypass combined
with a valve procedure from 1988 to 2003 at a University
teaching hospital by a single consultant were identified
from the database. Patient data was gathered retrospec-
tively from the case notes and operation records. Of the
total 237 patients, 41(29 male and 12 female) had CE in
addition to the coronary bypass and a valve procedure.
Each of these patients had either a single, double or triple
valve repair/replacement with a bioprosthesis or a
mechanical prosthesis and had single or multiple coro-
nary grafts with either vein and/or left internal mammary
artery.
The decision to perform endarterectomy was based on the
preoperative angiograms and intraoperative findings.
They included arteries with 100% proximal occlusion
with no distal lumen or subtotal occlusion with diffuse
atheroma. In some patients more than one coronary
artery were endarterectomised.
CPB with cooling to 30 degrees Celsius was established
using standard aortic and right atrial cannulations. Myo-
cardial protection was effected by intermittent cold blood
cardioplegia antegradely through aortic root and proxi-
mal end of completed vein graft, and in some cases retro-
gradely. The topical myocardial cooling was used in all
cases. The valve repair/replacements were done using the
standard techniques. CE was done by opening the dis-
eased coronary artery directly over the plaque and then by
developing a plane between the adventitia and the plaque
by hydro-dissection with a handheld syringe with cold
saline and 20 French AbbocathR (Abbott Laboratories).
Adequate distal clearance was confirmed by a tapered
thinned out distal segment of intima at the end of the
atheromatous plaque. In selected cases a further distal
arteriotomy was performed for completion of endarterec-
tomy in cases of broken atheroma and in these cases the
distal incision was closed with a vein patch.
All patients were anticoagulated for 6 months with Warfa-
rin until 2002, when we started using a combination of
antiplatelet agents for the aftercare of endarterectomy.
These patients currently receive 300 mgs of Aspirin per
rectally 6 hours after the procedure and are started on reg-
ular Aspirin 75 mgs and Clopidogrel 75 mgs daily from
the first postoperative day. Clopidogrel is continued for 6
months postoperatively and Aspirin lifelong. Patients in
atrial fibrillation or those with mechanical valves are still
anticoagulated with Warfarin and aspirin.
Demographic variables, preoperative symptom status, co-
morbid risk factors, operative details and postoperative
events indicating morbidity and mortality were recorded.
All patients were followed up at regular intervals in the
outpatient clinic and the latest follow up was obtained by
telephone interview at the start of the study with regards
to their current symptom status, need for nitrates, hospital
readmissions, and re-interventions.
All the data were stored on the database and were ana-
lyzed using SPSS 11.0. Continuous variables were
expressed as mean ± SD and categorical variables were
expressed as absolute numbers. All variables were ana-
lyzed with univariate analysis to determine whether any
single factor influenced hospital mortality. Wilcoxon
rank-sum test (for variables recorded on a continuous
scale) or Fisher's exact test (for categorical variables) were
used. Variables that achieved a P value less than .05 were
considered significant. Attempt was made to analyze sig-
nificant variables by multivariate analysis using logistic
regression to evaluate independent risk factors for hospi-
tal mortality after surgical intervention. However in view
of small number of study patients the data was too sparse
to allow any such model to be constructed.
Survival data were analyzed by using the standard Kaplan
Meier actuarial technique for estimation of survival prob-
abilities.
Results
Data on 41 patients, who had CE while undergoing coro-
nary bypass with valve surgery, was analyzed for factors
associated with in-hospital mortality and postoperative
survival. The postoperative morbidity and symptom relief
at follow up were also noted.
Factors associated with in-hospital mortality
Four patients died within the first 30 days after surgery.
Variables, which might have been associated with mortal-
ity, were identified and the association tested for statistical
significance, using either the Wilcoxon rank-sum test (for
variables recorded on a continuous scale) or Fisher's exact
test (for categorical variables).
Factors, which were statistically significant at the 5% level,
were EuroSCORE (p-value 0.016), logEuro (p-value
0.019), severity of angina (0.012), and the presence of a
pacemaker (p-value 0.007). The p-values for all the varia-
bles considered are listed in table 1 and 2.Journal of Cardiothoracic Surgery 2008, 3:15 http://www.cardiothoracicsurgery.org/content/3/1/15
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A higher EuroSCORE was associated with increased mor-
tality. The patients who survived had a median Euro-
SCORE of 7, while those who died had a median
EuroSCORE of 10, giving an observed difference of 3. The
95% confidence interval for this difference was 1–11.
A higher LogEuro score was also associated with increased
mortality. The median LogEuro for the two groups were
6.95 (survivors) and 16.55 (deaths), giving an observed
difference in medians of 9.6 with a 95% confidence inter-
val of 1.59–72.25.
Of 4 patients with unstable angina 3 died, while only 1 of
the 37 patients with stable angina died. The observed
odds ratio (i.e. the odds of dying for patients with unsta-
ble angina divided by the odds of dying for patients with
stable angina) was 24.75, while the 95% confidence inter-
val for this odds ratio was 1.38–1321.
Presence of a permanent pacemaker had an extremely low
p-value. Only 2 patients had pacemakers, and both these
patients died.
Of the four patients who died in hospital only two had
peri-operative infarct. One died of cerebro-vascular acci-
dent and the other due to sepsis and multi-organ failure.
The in-hospital mortality rate observed in this study was
9.8%.
Several cardiac and intraoperative variables were also
recorded and table 3 and 4 show the p-values measuring
the association between the operating characteristics and
mortality. Several of these p-values are small.
Post operative infarct (p-value 0.021), low cardiac output
(p-value 0.001), cardiac arrest (p-value 0.007), use of
vasoconstrictors (p-value 0.039) and use of IABP (p-value
0.0003) were associated with an increased risk of mortal-
ity. Morbidity following these operations was also
recorded (table 5).
Preoperative symptom status in terms of angina and dys-
pnoea was also compared. The bar charts figure 1(a–d)
illustrate the preoperative symptom status and the status
at follow up.
Long-term survival
The long-term survival of the 41 patients was studied.
During the recorded follow-up time (between 0 and 15
years), a total of 10 deaths occurred including those
immediately following the operation. A Kaplan-Meier sur-
vival curve showing the estimated survival probabilities
and associated 95% confidence intervals is given in figure
2. The "latest" death occurred 10 years after the operation.
The estimated survival rate at 10 years (or longer as no fur-
ther deaths occurred) is 57.2% with a 95% confidence
interval of 37.8%–86.6%.
All the late (post-hospitalization) deaths have not been
confirmed to be due to causes related to the coronary
bypass surgery. If any of these deaths were in fact due to
other causes, the actual estimated survival could have
been higher. One died due to endocarditis and another
due to congestive cardiac failure. Cause of death in 4 of
late deaths could not be confirmed.
Discussion
CE as a means for achieving complete revascularization
has been practiced since 1950's. Bailey et al first per-
formed it in 1956 at Hahnemann Hospital in Philadel-
phia. [1] Since then, various techniques have been
described including the open and closed method. Carbon
dioxide gas, laser, cardioplegia infusion, and other tech-
niques have been used to separate the plane of atheroma
to facilitate endarterectomy. [4-6]
Table 1: Demographic Characteristics
Variable Patients Number dead P value
Total number of patients 41 10(4***) 0.302
Males 29 7(4***)
Females 12 3(0***)
Age 67.4 ± 8.1** 0.086
BMI 26.3 ± 3.3** 0.583
Euroscore 7.6 ± 3.2** 0.016*
Log Euro 12.2 ± 16.1** 0.019*
Severity
Stable angina 34 1 0.012*
Unstable angina 7 3
*Significant at P < 0.05
** Mean ± 1 Standard Deviation
*** In hospital mortalityJournal of Cardiothoracic Surgery 2008, 3:15 http://www.cardiothoracicsurgery.org/content/3/1/15
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The initial enthusiasm has been dampened by the
reported increase in mortality and morbidity following
these procedures and poorer long-term graft patency in
endarterectomised vessels. [7,8] One possible caution in
CE is that the removal of distal atheroma has to be com-
plete as otherwise partially removed plaques could result
in regional ischemia and perioperative infarction. There is
no uniform agreement amongst surgeons in the field of
CE. Those with surgical expertise in this operation seem to
do more whereas others tend to graft distally or in certain
cases do not attempt to graft severely atheromatous arter-
ies. Sequential grafting is appropriate when the recipient
coronary artery have a reasonable lumen. In extenstive
atheromatous this may not give satisfying results.
However, the changing patient population over last dec-
ade has forced surgeons to look up at the surgical option
of CE again. Over the last few years, many reports suggest
that the initial impressions about the mortality and mor-
bidity may not have been true and CE may be a good way
of providing better symptomatic relief and survival in this
group of patients with more diffuse disease.
Table 2: Variables studied for in hospital mortality
Risk Factor N Dead P Value
Congestive Cardiac Failure
Yes 25 3 1.000
No 16 1
Past Myocardial Infarct
Yes 19 2 1.000
No 22 2
Redo Surgery
Yes 6 1 0.483
No 35 3
Cardiomegaly on X-ray
Yes 19 3 0.321
No 22 1
Previous Cardiological Intervention
Yes 4 1 0.348
No 37 3
Neurological Dysfunction
Yes 5 1 0.418
No 36 3
Diabetes
Yes 8 0 0.569
No 33 4
Hypercholesterolaemia
Yes 19 2 1.000
No 22 2
Hypertension
Yes 29 2 0.567
No 12 2
Hypothyroidism
Yes 1 0 1.000
No 40 4
Smoking
Current smoker 09 1 0.645/1
Non smoker 32 3
Family history of IHD
Yes 16 2 0.637
No 25 2
Gastrointestinal
Yes 4 1 0.348
No 37 3
Renal
creatinine<160 mg/dl 40 3 0.098
creatinine >300 mg/dl 1 1
Respiratory
Yes 3 0 1.000
PVD
Yes 8 0 0.569
No 33 4
Cerebrovascular
Yes 7 1 0.542
No 34 3
Rhythm
Sinus rhythm 34 3 0.542
Others 7 1
Pacemaker
Yes 2 2 0.007*
No 39 2
Nitrates
Yes 1 0 1.000
No 40 4
Table 3: Cardiac Variables
Variable N Dead P value
Extent of Coronary Disease
Single Vessel 4 0 0.184
Double Vessel 13 2
Triple Vessel 24 2
Left Main Stem
Yes 2 1 0.188
No 39 3
PA Wedge
<20 cm 29 1 0.068
>20 cm 12 3
Valve requiring surgery
Aortic 20 2 1.000
Mitral 18 2
Double (aortic + mitral) 03 0
LV Function
Poor 10 2 0.446
Moderate 13 1
Good 18 1
Number of distal anastomoses
Single 4 0 0.233
Double 15 3
Triple 16 0
More than triple 6 1
Vessel requiring endarterectomy
RCA 31 2 0.245
LAD 6 1
Multiple 4 1
Valve procedure
Repair 14 1 1.000
Replacement 27 3Journal of Cardiothoracic Surgery 2008, 3:15 http://www.cardiothoracicsurgery.org/content/3/1/15
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Recent literature has looked at the issues of mortality and
morbidity in patients undergoing CE in isolated coronary
bypass operations. Typically reported rates have been
between 0%–15% over the last fifteen years with postop-
erative myocardial infarction rates being 5–25% [9]. Asi-
makopoulos et al have reported mortality of 3.6% in their
study group of patients, which was not statistically differ-
ent from the mortality in the control group, suggesting
that with improved safety in modern surgery mortality is
not increased in patients requiring CE. Survival rates of
71–92% at five years have been shown in previous stud-
ies, however long term survival in these groups of patients
is not known. [10]
With increasing use of off pump coronary bypass, isolated
groups have reported CE in this subgroup with good ini-
tial results. Eryilmaz et al have reported no mortality with
100% patency rates on angiographies done at one year
and have further strengthened the concept of need and
justification for complete revascularization in patients
with severe diffuse atherosclerotic disease and poor LV
function. [11]
Mortality in the group of patients undergoing combined
valve surgery with coronary bypass has traditionally been
higher. In this group of patients the general approach is to
keep the operations as simple as possible with minimum
being done to keep the operative time less and thereby
hoping to keep the mortality down.
The association of valve disease (particularly of mitral
valve) requiring concomitant surgery in patients undergo-
ing bypass and endarterectomy has been reported to be an
IABP
Yes 1 1 0.098
No 40 3
Priority
Elective 38 3 0.271
Urgent 3 1
*Significant at P < 0.05
Table 2: Variables studied for in hospital mortality (Continued)
Table 4: Operative Variables
Variable N Dead P Value
Cross Clamp Time 94.5+24.1 0.947
Re exploration
No 36 0 1.000
Yes 5 4
Peri operative Infarct
Yes 3 2 0.021
No 38 2
Low Cardiac output
Yes 9 4 0.001*
No 32 0
Ionotropes
Yes 27 4 0.280
No 14 0
Vasoconstrictors
Yes 10 3 0.039*
No 31 1
IABP
Yes 7 4 0.0003*
No 34 0
Arrhythmia
SR 21 1 0.203
AF/SVT 18 2
VF/VT 2 1
Arrest
Yes 2 2 0.007*
No 39 2
Temporary Pacing
Yes 16 1 1.000
No 25 3
Ventilation duration
<48 hr 33 2 0.165
>48 hrs 8 2
PPM
Yes 3 1 0.271
No 38 3
* Significant at P < 0.05
Table 5: Morbidity
Variable N
Neurological Complication
Yes 4
No 37
Renal impairment requiring filter
Yes 1
No 40
Gastrointestinal Complications
Yes 1
No 40
Sternal Wound Infection
Yes 2
No 39
Tracheostomy
Yes 5
No 36
Sepsis
Yes 1
No 40
Multi-organ failure
Yes 1
No 40
ITU Stay
<48 hours 32
>48 hours 9
Hospital Stay 12.7 + 10.43
Readmission to ITU 1
Re intervention
Medical 1
Surgical 0Journal of Cardiothoracic Surgery 2008, 3:15 http://www.cardiothoracicsurgery.org/content/3/1/15
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independent, risk factor for increased mortality. In this
same study aortic valve replacement was associated with
increased risk of peri-operative MI. [12]
This is a retrospective analytical observation of the out-
come of surgery specially in patients who had CE in addi-
tion valve surgery. The data goes back to 1988 before the
advent of statistical markers such as EuroScore. [13]
Hence it is difficult to compare this group with conven-
tional CABG and valve surgery.
The United Kingdom Cardiac Surgical Register for the
financial year ending 2001 reported mortality rate of
7.8% (224 patients died out of a total of 2,881) for
patients undergoing combined valve surgery and coronary
bypass [14]. Comparing these figures with our data on
patients also undergoing endarterectomy (mortality rate
of 9.8%), there was no evidence of a statistically signifi-
cant increase in mortality for the patients undergoing
endarterectomy (p-value of 0.56 using Fisher's exact test).
The observed odds ratio was 1.28 (95% CL 0.33–3.62).
The median postoperative hospital stay reported in the
register for valve procedures combined with coronary
bypass was 8 days [14] which compares favorably with
our group of patients who had a median stay of 7 days.
Comparing the results between the endarterectomised
and non-endarterectomised vessels is controversial. There
is a general agreement on the fact that endarterectomy is
done only for vessels which are near totally occluded with
poor run offs, thus implying more severe disease process.
In this scenario, is it justified comparing an endarterec-
(a-d): Bar Charts comparing the symptom status before the surgery and at follow up Figure 1
(a-d): Bar Charts comparing the symptom status before the surgery and at follow up.
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tomy group with one, which does not undergo endarter-
ectomy ? Perhaps, in these situations, results are best
judged by the long-term symptom free status and survival
rather than the patency of the grafts per se.
Livesay et al in their series of endarterectomies noted the
fact that the patients in the endarterectomy group differed
significantly from others in gender, diabetes low ejection
fraction and increased number of bypassed vessels, thus
implying sicker patients with more severe disease. In their
study they did not find significant differences in the mor-
tality, long-term survival, symptom benefit and freedom
from reoperations especially in the group of patient who
were operated in the later era with improved techniques
for myocardial protection and better anticoagulation
drugs. They believe that in patients with more diffuse dis-
ease this forms a good option to provide as good results as
those with less severe disease. [2]
The issue of increased risk with left sided endarterecto-
mies has not been conclusively proven and some studies
have shown satisfactory results [15]. Silberman S et al
have shown that patients requiring left anterior descend-
ing artery endarterectomy are at an increased risk of oper-
ative mortality. [16] Sundt et al have shown that there is
no difference in the incidence of perioperative MI or dys-
arrhythmias in between various vessels endarterect-
omised. They had a 75–76% actuarial survival at 5 years
with 74% being angina free. Only 3% had required a redo
surgery in long term follow up [17]. In our group of
patients we also did not note any difference in mortality
in different vessels endarterectomised.
Ferraris et al have earlier shown a reduced long-term ang-
iographic patency in their group of patients. In this group
the patency was 40% for the endarterectomised vessels in
the study group as compared to 58% patency for the non-
endarterectomised vessels in the same group. The patency
rate was reported to be 65% in the control group [7]. This
discrepancy in the patency between the control group and
the non-endarterectomised vessels of the study group may
reflect the more severe disease in the study group in the
first place. This study may also have included a bias due to
the fact that it was done by selecting retrospectively, the
patients who had undergone repeat catheterization. This
would have possibly included only those patients with
problems and symptoms and would not have taken into
account the total number of endarterectomised patients
during the study period that probably did not require a re-
angiography as they were symptom free. Thus it would
have picked up a falsely high number of blocked grafts
wrongly attributed to endarterectomy. Also endarterec-
tomy was done only for patients with unsuitable vessel for
grafting; thus without endarterectomy and grafting the
area would be ischemic in 100% of the patients but by
doing the procedure it provided revascularization for at
least 40% of the patients over a long follow up period.
Brenowitz et al stratified operative mortality and long
term survival according to the presence of additional risk
factors such as left ventricular dysfunction, repeat opera-
tion, diabetes, female sex, and age over 70. The results
showed increased operative mortality and morbidity;
however better survival and clinical status with continued
graft patency justified this approach in patients with dif-
fuse coronary artery disease many of whom would other-
wise have been deemed inoperable. [3]
A 2.3%mortality and 85% patency at 15.4 months have
been reported by Frazone et al[18], Doss et al, however,
claim better patency with the plaque bridging anastomo-
ses [19] but this type of anastomoses may not be suitable
for patients with no distal runoff.
Djalilian and Shumway have shown patency rates of 83%
at 1 year and 75% at average interval of 37 months. Their
incidence of MI was 5% and mortality of 3%. [9]
Keogh et al have used angioscopy to assess the complete-
ness of endarterectomies. [20] They have shown that this
can be used for confirming the completeness of the endar-
terectomy without increasing ischemic time. In their
group of patients they showed that the small side
branches were not compromised.
Incomplete endarterectomy may have a snow-plough
effect leading to the occlusion of side branches. The
increased thrombogenicity of the raw area may also con-
Kaplan-Meier Survival curve showing the estimated survival  probabilities Figure 2
Kaplan-Meier Survival curve showing the estimated survival 
probabilities.Journal of Cardiothoracic Surgery 2008, 3:15 http://www.cardiothoracicsurgery.org/content/3/1/15
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tribute to higher occlusion rate and post op infarction.
Better results can be achieved by ensuring completeness of
the endarterectomy and by better anticoagulation man-
agement. The variable results noted in different series with
improved results in later ones might be reflective of this
fact.
In a study by Tasdemir et al, the actuarial survival at 7
years after endarterectomy was better than simple patch
reconstruction and bypass (94%v/s 74.8%, p = 0.008)
reflecting a complete removal of the atherosclerotic mate-
rial and complete revascularization in the endarterectomy
group of patients. This study also concluded that the life
expectancy, functional capacity, and working status of
patients who underwent endarterectomy was comparable
to those in the control group with possibly less extensive
disease. [21]
Factors determining the outcome of operative correction
of valvular abnormalities combined with coronary artery
bypass grafting are still incompletely defined. Increasing
age, female sex, renal failure, advanced New York Heart
Association class, left ventricular function, mitral regurgi-
tation, coronary disease, cardiac arrrhythmia and the
operative ischemic time are all important predictors of
adverse clinical outcome after combined valve operations
and coronary artery bypass grafting. Five and 10 year sur-
vival probabilities of 74% (95% CL of 71% – 78%) and
43% (95% CL 36% – 50%), respectively have been
reported [22]. Mitral valve disease is associated with
poorer long-term outcomes with 10 year actuarial survival
rates of 33% (95%CL 22% – 47%) in the ischemic group
and 52% (95%CL 42%–64%) in the degenerative group.
Survival after mitral valve surgery and CABG is deter-
mined by the extent of coronary disease, ventricular dys-
function and by the success of the valve procedure.
Etiology of mitral valve regurgitation has relatively little
impact on late outcome.
Mullany CJ et al in their study have shown that delinea-
tion of coronary artery disease and revascularization
decreases the mortality of aortic valve surgery. [23] Early
improvement in ejection fraction, influenced by coexist-
ent coronary artery disease and gender-associated factors,
significantly affects subsequent survival. [24]
The extent of coronary artery disease is an important pre-
dictor for long-term survival after combined valve and
coronary bypass operations. [25] Complete revasculariza-
tion in this group of patients we believe is even more
important for better long-term survival.
In our group we had 57.2% (95%CL 37.8% – 86.6%) sur-
vival at 10 years (which includes deaths from all causes),
which is better than that reported in literature. Thus
endarterectomy might be indirectly providing a survival
advantage and should be seriously considered in appro-
priate patients with diffuse disease.
Conclusion
The long-term survival in patients with combined valvular
and coronary artery disease is determined by the extent of
coronary disease. On comparison with the published out-
come data from SCTS database, the results from this retro-
spective observational study has shown that CE does not
increase the mortality or morbidity in this small complex
cohort of patients. CE in diffuse coronary artery disease
facilitates complete revascularization and hence possibly
offers survival benefit. In view of the small numbers in our
group, this requires to be validated by a multicentre study
with larger number of patients.
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